Harish K, Nitha R, Harikumar R, Sunil Kumar K, Varghese Thomas, Sreedevi N S, Bushrath K, Sandesh K, Tony J
Calicut Medical College, Kozhikode 673 008, Kerala.
Trop Gastroenterol. 2005 Oct-Dec;26(4):188-93.
Abnormalities in liver function tests (LFT) during pregnancy are a commonly encountered problem often associated with serious consequences especially when it occurs in the third trimester. The spectrum of abnormal liver functions in pregnancy can be fairly wide and diagnostic work up often challenging. There is insufficient prospective data on the spectrum and outcome of liver disease in pregnant population from south India. This study was performed to assess the causes of deranged liver function in the pregnant population and also to prospectively determine the outcome of liver dysfunction in pregnancy. All abnormal LFT results observed in serum samples from pregnant patients attending the obstetric unit of our hospital from January 2003 to January 2005 were evaluated and prospectively followed throughout pregnancy. Laboratory investigations included coagulation profile, renal function tests, serology for viral markers (HBsAg, anti-HCV, IgM anti-HEV and IgM anti-HAV) and other relevant biochemical tests. In those with liver dysfunction in the third trimester the maternal and perinatal outcome was evaluated. A total of 125 patients were identified with abnormalities in LFT results during this period. The majority of causes were related to pregnancy specific conditions (57.6%). Most episodes of abnormal LFT occurred in the third trimester (59.2%). Hyperemesis gravidarum (55.8%) and viral hepatitis (47%) were the most common causes of abnormal LFT in the first and second trimesters respectively. HELLP (28.3%) and AFLP (14.8%) were the most common causes of abnormal LFT in the third trimester. There were no mAternal deaths due to liver dysfunction in the first or second trimester. Liver dysfunction in the third trimester (74 patients) was associated with serious consequences. DIC was the most common complication (20.2%). The overall and perinatal mortality was 20.2% and 24.6% respectively. AFLP and HELLP syndromes were associated with poor maternal and fetal outcome. We conclude that liver dysfunctions were directly related to pregnancy in the majority of patients especially in the third namely trimester. Incidence of the most serious conditions AFLP and HELLP syndromes is much greater than what has been reported and is often associated with a high maternal mortality and poor perinatal outcome.
孕期肝功能检查(LFT)异常是一个常见问题,常伴有严重后果,尤其是在孕晚期出现时。孕期肝功能异常的范围可能相当广泛,诊断工作往往具有挑战性。关于印度南部孕妇肝病的范围和结局,前瞻性数据不足。本研究旨在评估孕妇肝功能紊乱的原因,并前瞻性地确定孕期肝功能障碍的结局。对2003年1月至2005年1月在我院产科就诊的孕妇血清样本中观察到的所有异常LFT结果进行评估,并在整个孕期进行前瞻性随访。实验室检查包括凝血指标、肾功能检查、病毒标志物血清学检查(HBsAg、抗HCV、IgM抗HEV和IgM抗HAV)以及其他相关生化检查。对孕晚期肝功能障碍的孕妇评估其母婴结局。在此期间共确定125例LFT结果异常的患者。大多数病因与妊娠特定情况有关(57.6%)。大多数LFT异常情况发生在孕晚期(59.2%)。妊娠剧吐(55.8%)和病毒性肝炎(47%)分别是孕早期和孕中期LFT异常的最常见原因。HELLP(28.3%)和AFLP(14.8%)是孕晚期LFT异常的最常见原因。孕早期或孕中期没有因肝功能障碍导致的孕产妇死亡。孕晚期肝功能障碍(74例患者)伴有严重后果。弥散性血管内凝血(DIC)是最常见的并发症(20.2%)。总体死亡率和围产儿死亡率分别为20.2%和24.6%。AFLP和HELLP综合征与母婴不良结局相关。我们得出结论,大多数患者的肝功能障碍与妊娠直接相关,尤其是在孕晚期。最严重的疾病AFLP和HELLP综合征的发病率远高于已报道的情况,且常伴有高孕产妇死亡率和不良围产儿结局。